Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (191-200 of 470) with videos related to

Pageof 47
Sort By:
Translational Lung Cancer Research|March 10, 2023
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative reviewMariacarmela Santarpia, Giuliana Ciappina, Calogera Claudia Spagnolo, et al.
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeting PD-1/PD-L1 in lung cancer: current perspectivesMaría González-Cao, Niki Karachaliou, Santiago Viteri, et al.
Scientific Reports|February 13, 2021
Analysis of extracellular vesicle mRNA derived from plasma using the nCounter platformJillian W P Bracht, Ana Gimenez-Capitan, Chung-Ying Huang, et al.
Clinical Lung Cancer|April 23, 2005
Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgeryEnriqueta Felip, Miquel Taron, Rafael Rosell, et al.
The Journal of Liquid Biopsy|March 3, 2025
Liquid biopsy in detecting early non-small cell lung cancerRafael Rosell, Mariacarmela Santarpia, Carlos Pedraz-Valdunciel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patientsRafael Rosell, Kathleen D Danenberg, Vincente Alberola, et al.
Plos One|March 9, 2010
The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancerMireia Margeli, Beatriz Cirauqui, Eva Castella, et al.
Oncotargets and Therapy|March 15, 2018
Response to crizotinib in a non-small-cell lung cancer patient harboring an <i>EML4-ALK</i> fusion with an atypical <i>LTBP1</i> insertionCristina Aguado, Maria-de-Los-Llanos Gil, Zaira Yeste, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2010
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patientsCarlos Camps, Eloisa Jantus-Lewintre, Andrea Cabrera, et al.
Acta Pharmaceutica Sinica. B|April 24, 2020
Identification of a novel PAK1 inhibitor to treat pancreatic cancerJiaqi Wang, Yonghua Zhu, Jiao Chen, et al.
Pageof 47

Showing results (191-200 of 470) with videos related to

Sort By:
Pageof 47
Translational Lung Cancer Research|March 10, 2023
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative reviewMariacarmela Santarpia, Giuliana Ciappina, Calogera Claudia Spagnolo, et al.
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeting PD-1/PD-L1 in lung cancer: current perspectivesMaría González-Cao, Niki Karachaliou, Santiago Viteri, et al.
Scientific Reports|February 13, 2021
Analysis of extracellular vesicle mRNA derived from plasma using the nCounter platformJillian W P Bracht, Ana Gimenez-Capitan, Chung-Ying Huang, et al.
Clinical Lung Cancer|April 23, 2005
Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgeryEnriqueta Felip, Miquel Taron, Rafael Rosell, et al.
The Journal of Liquid Biopsy|March 3, 2025
Liquid biopsy in detecting early non-small cell lung cancerRafael Rosell, Mariacarmela Santarpia, Carlos Pedraz-Valdunciel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patientsRafael Rosell, Kathleen D Danenberg, Vincente Alberola, et al.
Plos One|March 9, 2010
The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancerMireia Margeli, Beatriz Cirauqui, Eva Castella, et al.
Oncotargets and Therapy|March 15, 2018
Response to crizotinib in a non-small-cell lung cancer patient harboring an <i>EML4-ALK</i> fusion with an atypical <i>LTBP1</i> insertionCristina Aguado, Maria-de-Los-Llanos Gil, Zaira Yeste, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2010
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patientsCarlos Camps, Eloisa Jantus-Lewintre, Andrea Cabrera, et al.
Acta Pharmaceutica Sinica. B|April 24, 2020
Identification of a novel PAK1 inhibitor to treat pancreatic cancerJiaqi Wang, Yonghua Zhu, Jiao Chen, et al.
Pageof 47